EP0785714A1 - Antimicrobial composition - Google Patents
Antimicrobial compositionInfo
- Publication number
- EP0785714A1 EP0785714A1 EP95934953A EP95934953A EP0785714A1 EP 0785714 A1 EP0785714 A1 EP 0785714A1 EP 95934953 A EP95934953 A EP 95934953A EP 95934953 A EP95934953 A EP 95934953A EP 0785714 A1 EP0785714 A1 EP 0785714A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- diol
- composition according
- percent
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 40
- 150000001735 carboxylic acids Chemical class 0.000 claims abstract description 25
- 238000011282 treatment Methods 0.000 claims abstract description 17
- 229920000642 polymer Chemical class 0.000 claims abstract description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 9
- 238000005470 impregnation Methods 0.000 claims abstract description 8
- 238000004140 cleaning Methods 0.000 claims abstract description 7
- 238000004381 surface treatment Methods 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- 229920000728 polyester Chemical class 0.000 claims abstract description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- 230000000249 desinfective effect Effects 0.000 claims abstract description 4
- 150000002148 esters Chemical class 0.000 claims abstract description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 118
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 75
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 60
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 42
- 239000004310 lactic acid Substances 0.000 claims description 37
- 235000014655 lactic acid Nutrition 0.000 claims description 37
- 239000003795 chemical substances by application Substances 0.000 claims description 32
- 150000002009 diols Chemical class 0.000 claims description 31
- 229940051250 hexylene glycol Drugs 0.000 claims description 29
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 18
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 17
- 239000000654 additive Substances 0.000 claims description 16
- 235000011054 acetic acid Nutrition 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- -1 aromatic dicarboxylic acids Chemical class 0.000 claims description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 10
- 241000700605 Viruses Species 0.000 claims description 9
- 239000004202 carbamide Substances 0.000 claims description 9
- 235000015165 citric acid Nutrition 0.000 claims description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 8
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 7
- 229920000615 alginic acid Polymers 0.000 claims description 7
- 235000010443 alginic acid Nutrition 0.000 claims description 7
- 239000000499 gel Substances 0.000 claims description 7
- 239000011975 tartaric acid Substances 0.000 claims description 7
- 235000002906 tartaric acid Nutrition 0.000 claims description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 4
- 241000555688 Malassezia furfur Species 0.000 claims description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 4
- 150000004781 alginic acids Chemical group 0.000 claims description 4
- 208000010668 atopic eczema Diseases 0.000 claims description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 claims description 4
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 claims description 4
- 241001529453 unidentified herpesvirus Species 0.000 claims description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical group O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 201000004624 Dermatitis Diseases 0.000 claims description 3
- 241000589516 Pseudomonas Species 0.000 claims description 3
- 239000005864 Sulphur Substances 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 239000000783 alginic acid Substances 0.000 claims description 3
- 229960001126 alginic acid Drugs 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 239000003443 antiviral agent Substances 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 claims description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 241000228212 Aspergillus Species 0.000 claims description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 2
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 claims description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims description 2
- 241001480037 Microsporum Species 0.000 claims description 2
- 241000191940 Staphylococcus Species 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- 241000223238 Trichophyton Species 0.000 claims description 2
- 208000000260 Warts Diseases 0.000 claims description 2
- 239000001361 adipic acid Substances 0.000 claims description 2
- 235000011037 adipic acid Nutrition 0.000 claims description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 2
- 208000002399 aphthous stomatitis Diseases 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 2
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical compound CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 239000001530 fumaric acid Substances 0.000 claims description 2
- 239000003862 glucocorticoid Substances 0.000 claims description 2
- 229940097043 glucuronic acid Drugs 0.000 claims description 2
- 208000006454 hepatitis Diseases 0.000 claims description 2
- 231100000283 hepatitis Toxicity 0.000 claims description 2
- MHIBEGOZTWERHF-UHFFFAOYSA-N heptane-1,1-diol Chemical compound CCCCCCC(O)O MHIBEGOZTWERHF-UHFFFAOYSA-N 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- FVXBCDWMKCEPCL-UHFFFAOYSA-N nonane-1,1-diol Chemical compound CCCCCCCCC(O)O FVXBCDWMKCEPCL-UHFFFAOYSA-N 0.000 claims description 2
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 claims description 2
- 229960002446 octanoic acid Drugs 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 2
- 229940107700 pyruvic acid Drugs 0.000 claims description 2
- 201000010153 skin papilloma Diseases 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 229940037128 systemic glucocorticoids Drugs 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- 229940005605 valeric acid Drugs 0.000 claims description 2
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 claims 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 229960004063 propylene glycol Drugs 0.000 description 39
- 235000013772 propylene glycol Nutrition 0.000 description 39
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 27
- 101150002764 purA gene Proteins 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000002023 wood Substances 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 206010040844 Skin exfoliation Diseases 0.000 description 7
- 239000010985 leather Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000000645 desinfectant Substances 0.000 description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 5
- 239000012459 cleaning agent Substances 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000004753 textile Substances 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 239000004599 antimicrobial Substances 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 150000002334 glycols Chemical class 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 235000011941 Tilia x europaea Nutrition 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000002009 allergenic effect Effects 0.000 description 3
- 229940016389 aluminium acetotartrate Drugs 0.000 description 3
- KQVRYPWCDUCYPZ-OLXYHTOASA-K aluminum;(2r,3r)-2,3-dihydroxybutanedioate;acetate Chemical compound [Al+3].CC([O-])=O.[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O KQVRYPWCDUCYPZ-OLXYHTOASA-K 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001857 anti-mycotic effect Effects 0.000 description 3
- 239000004571 lime Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 239000010893 paper waste Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 206010021639 Incontinence Diseases 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 229920002522 Wood fibre Polymers 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000002543 antimycotic Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 230000037072 sun protection Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000002025 wood fiber Substances 0.000 description 2
- MQHLMHIZUIDKOO-OKZBNKHCSA-N (2R,6S)-2,6-dimethyl-4-[(2S)-2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine Chemical compound C1=CC(C(C)(C)CC)=CC=C1C[C@H](C)CN1C[C@@H](C)O[C@@H](C)C1 MQHLMHIZUIDKOO-OKZBNKHCSA-N 0.000 description 1
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- SLZWEMYSYKOWCG-UHFFFAOYSA-N Etacelasil Chemical compound COCCO[Si](CCCl)(OCCOC)OCCOC SLZWEMYSYKOWCG-UHFFFAOYSA-N 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 239000004146 Propane-1,2-diol Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229960003204 amorolfine Drugs 0.000 description 1
- 230000001046 anti-mould Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000007798 antifreeze agent Substances 0.000 description 1
- 239000002546 antimould Substances 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 229940028000 biguanides and amidines as antiseptic and disinfectant Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- QTPGEBNYYFYLFS-UHFFFAOYSA-N butane-1,3-diol;propane-1,2-diol Chemical compound CC(O)CO.CC(O)CCO QTPGEBNYYFYLFS-UHFFFAOYSA-N 0.000 description 1
- ORYUEUVBCGMQHY-UHFFFAOYSA-N butane-1,4-diol;2-methylpentane-2,4-diol Chemical compound OCCCCO.CC(O)CC(C)(C)O ORYUEUVBCGMQHY-UHFFFAOYSA-N 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 229960002242 chlorocresol Drugs 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002173 cutting fluid Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940000033 dermatological agent Drugs 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002289 effect on microbe Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001329 hyperkeratotic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229960003128 mupirocin Drugs 0.000 description 1
- 229930187697 mupirocin Natural products 0.000 description 1
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- MEUIIHOXOWVKNP-UHFFFAOYSA-N phosphanylformic acid Chemical compound OC(P)=O MEUIIHOXOWVKNP-UHFFFAOYSA-N 0.000 description 1
- 201000000508 pityriasis versicolor Diseases 0.000 description 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
- 229960001237 podophyllotoxin Drugs 0.000 description 1
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- MTTKOBXFUGIESR-UHFFFAOYSA-N prop-1-ene-1,3-diol Chemical compound OCC=CO MTTKOBXFUGIESR-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2075—Carboxylic acids-salts thereof
- C11D3/2086—Hydroxy carboxylic acids-salts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2003—Alcohols; Phenols
- C11D3/2041—Dihydric alcohols
- C11D3/2044—Dihydric alcohols linear
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2075—Carboxylic acids-salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2075—Carboxylic acids-salts thereof
- C11D3/2079—Monocarboxylic acids-salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2075—Carboxylic acids-salts thereof
- C11D3/2082—Polycarboxylic acids-salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B27—WORKING OR PRESERVING WOOD OR SIMILAR MATERIAL; NAILING OR STAPLING MACHINES IN GENERAL
- B27K—PROCESSES, APPARATUS OR SELECTION OF SUBSTANCES FOR IMPREGNATING, STAINING, DYEING, BLEACHING OF WOOD OR SIMILAR MATERIALS, OR TREATING OF WOOD OR SIMILAR MATERIALS WITH PERMEANT LIQUIDS, NOT OTHERWISE PROVIDED FOR; CHEMICAL OR PHYSICAL TREATMENT OF CORK, CANE, REED, STRAW OR SIMILAR MATERIALS
- B27K3/00—Impregnating wood, e.g. impregnation pretreatment, for example puncturing; Wood impregnation aids not directly involved in the impregnation process
- B27K3/34—Organic impregnating agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B27—WORKING OR PRESERVING WOOD OR SIMILAR MATERIAL; NAILING OR STAPLING MACHINES IN GENERAL
- B27K—PROCESSES, APPARATUS OR SELECTION OF SUBSTANCES FOR IMPREGNATING, STAINING, DYEING, BLEACHING OF WOOD OR SIMILAR MATERIALS, OR TREATING OF WOOD OR SIMILAR MATERIALS WITH PERMEANT LIQUIDS, NOT OTHERWISE PROVIDED FOR; CHEMICAL OR PHYSICAL TREATMENT OF CORK, CANE, REED, STRAW OR SIMILAR MATERIALS
- B27K3/00—Impregnating wood, e.g. impregnation pretreatment, for example puncturing; Wood impregnation aids not directly involved in the impregnation process
- B27K3/34—Organic impregnating agents
- B27K3/50—Mixtures of different organic impregnating agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- Diols occur as solvents in various der- matological vehicles since then they are atoxic to skin epithel ⁇ ium.
- Propylene gycol is a commonly occurring solvent in derma- tolological vehicles.
- diols having longer carbon chains such as, for example, butylene glycol and hexylene glycol have recently started to be used in vehicles instead of propylene glycol, mainly due to their stronger antimicrobial properties.
- the Swedish patent No. 464060 relates to the use of pentane diol or hexane diol for preparing an agent for treating infections caused by the herpes virus.
- the Swedish patent application No. 8802257-9 relates to the use of a composition containing aluminium acetotartrate (alsol solution) and a diol having antimicrobial properties for preparing an agent aimed at reducing skin irritation, particular ⁇ ly in the nappy region. Furthermore, it has been reported that the killing of microorganisms is potentialized by the combination propylene glycol and aluminium acetotartrate.
- lactic acid (Acidum lacticum) has hygroscopic and acidifying properties and is included, i.a. in foodstuffs, skin preparations and soap products.
- WO 89/00853 relates to a treatment agent containing salicylic acid in combination with aliphatic 1,2-diol and fatty acid esters for local therapy for flaking skin diseases in human and veter ⁇ inary medicine.
- Salicylic acid has well known anti-flaking properties.
- WO 94/09755 discloses the use of salicylic acid in combination with propylene glycol for the treatment of flaking skin diseases, such as, eczema and psoriasis.
- salicylic acid is not included in the present invention.
- GB, Al 155 796 discloses the use of alkyl lactate in combination with alkylene glycol as a solvent for the treatment of acne. Certain carboxylic acids are used as buffers to adjust pH and prevent hydrolysis. Also GB, Al 1 388 836 and EP 0 150 914 discloses the use of alkyl lactate in combination with alkylene glycol (propylene glycol for example) as a solvent for the treatment of acne. Also Chemical Abstract, vol. 108 (1988), abstract No. 62508 IN, A, 157171 is relating to treatment of acne, viz. a specific skin disease.
- organic acids are used to dissolve iron oxide together with sorbitol as a surfactant.
- sorbitol can be replaced by glycols.
- DE, Cl 4311713 discloses the use of citric acid or tartaric acid dissolved in propylene glycol or polyethylene glycol.
- the composition is used on glass or plexiglass surfaces in shower cabinets where the acid has the role of dissolving deposits of lime and the glycol to give a sufficient viscosity so that the composition stays in place for the time it takes for the acid to work.
- Carboxylic acids have a similar function, in DE, Al 3042507 for the purpose of cleaning surfaces on enamelled goods. Additives of hygroscopically active diols may also be included.
- EP 0033 111 relates to a combination of organic acid and alcohol to mechanically loosen deposits of lime, oil and fat on the interior surface of dishwashers.
- Cleaning agents of today such as washing-up liquid, soap etc., which are often characterised by a basic pH-value, are easily contaminated and, furthermore, are hardly kind to the skin.
- Various additives often mean that the cleaning agents are no longer either environmentally kind or kind to the skin and thus are not readily accepted by the consumer. Neither is there currently a suitable agent for cleaning skin, leather, plastic, metal and wooden surfaces.
- the agents of today used for cleaning surfaces of biological material often contain ethyl alcohol and isopropanol, which appear to be desiccating.
- Peeling agents sometimes contain abrasives which may cause sores on the skin, which secondarily may act as an approach for bacteria, therefor an effective antimicrobial agent kind to the skin having peeling effect without harmful additives would fulfill a long sought after need.
- the forming of mould is also a great problem in the handling of wood and in waste paper recycling.
- the medical care of today lacks also a user-kind agent having effect on microbes on the skin and for the diseases caused by this.
- Antibiotic additives in skin preparations may cause resistance and allergy problems.
- compositions containing carboxylic acids or salts thereof having up to 10 carbon atoms and C 3 -C 10 -diols which give an increased antimicrobial effect and a wide antimicrobial spectrum having great inhibitory effect on several Dermatophytes, yeast fungi, mould fungi, bacteria and virus.
- the composition is furthermore kind to the skin, environmentally kind, low allergenic, keratoly- tic active and has also a hygroscopic effect and does not evaporate as fast as e.g. ethanol.
- an increased antimicrobial effect was obtained by a combination of diols and carboxylic acids according to the invention in tests on different microorganisms.
- C 3 -C 6 -diols were used.
- C 3 -C 10 -diols which may be used according to the invention are propylene glycol; butylene glycol; pentanediol, hexylene glycol, heptanediol, octanediol, nonanediol, decane- diol.
- carboxylic acids having up to 10 carbon atoms which may be used according to the invention, relates to saturated and un- saturated, straight and branched aliphatic mono-, di- and poly- carboxylic acids having up to 10 carbon atoms, araliphatic and aromatic dicarboxylic acids, oxy and hydroxy carboxylic acids having up to 8 carbon atoms.
- a chemical composition has the advantage over a mixture in that it is relatively stable and is not so easily leached with water, if, for example it is used for the purpose of impregnating. Since the chemical composition is biologically decomposable small amounts of carboxylic acid and diol may slowly be released, whereby the material maintains its antimicrobial effect during a significantly longer time. A bond between carboxylic acids and diols may be made more or less stable so that sufficiently large amounts of the decomposable products diol and carboxylic acid are released for adaptation for various purposes.
- a chemical fixing of the carboxylic acids and diols may be ach ⁇ ieved with the aid of polyester bonds or longer chains of diol and carboxylic acid together, so called polymers.
- a polymer of only lactic acid, so called polylactides, are used today for producing "non-woven" material, which, i.a. may be used for nappies, sutures and packing material. For these areas of use the possible antimicrobial effect of a material is of great importance.
- a chemical compound of diol and carboxylic acid has similar areas of use, i.e. in the production of nappies, dressings, sanitary products, sutures and packing materials, and also as an additive for wood and paper products.
- composition according to the invention may contain additives such as water, C x .C 8 -alcohols, oils preferably vegetable oils such as peanut oil, olive oil, rape seed oil, linseed oil, tall oil and castor oil with or without being combined with emulsifying agents. Also surfactants may be added to strengthen the cleansing effects. Urea and/or polyethylene glycol may also be included.
- additives may be antimycotics, preferably azole derivati ⁇ ves, allyl amines and amorolfine; antiviral agents, preferable idoxyuridine, acyclovir, phosphonio formic acid, podophyllotoxin; antibacterial agents such as biguanides and amidines, quinolines, benzoyl peroxide, bibrocatole, clindamycin, neomycin, fucidinic acid, mupirocin, sulphur; glucocorticoides, preferably hydrocor- tisone and flouro substituted steroids, gels and enzymes.
- antimycotics preferably azole derivati ⁇ ves, allyl amines and amorolfine
- antiviral agents preferable idoxyuridine, acyclovir, phosphonio formic acid, podophyllotoxin
- antibacterial agents such as biguanides and amidines, quinolines, benzoyl peroxid
- a composition comprising carboxylic acids or salts thereof, as defined above, and C 3 -C 10 - diols in products for cleansing, disinfection or antimicrobial effect, surface treatment and impregnating or for the production of biologically decomposable material.
- the invention comprises also mixtures of several carboxylic acids and diols where diols having shorter carbon chains serve as solvents for diols having longer carbon chains.
- carboxylic acid when in use according to the invention constitute 0.1-60 percent by weight and C 3 -C 10 -diol constitute 0.1-99.9 percent by weight.
- carboxylic acid 0.1-40 percent by weight carboxylic acid and 0.15-91 percent by weight diol is used.
- acetic acid citric acid, tartaric acid, lactic acid and 0.38-91 percent by weight
- propylene glycol butylene glycol, pentanediol and hexylene glycol is used, wherein one or several carboxylic acids and diols may be included.
- the minimal inhibitory concentration (MIC) for propylene glycol ( 100%) tested on the bacterium Staphylococcus aureus and the dermophyte Tricophyton rubrum dropped from 8 % to 0.15 % and 0.38 % respectively if lactic acid was mixed with propylene glycol in the ratios 3:10 or 2:3.
- the composition gave a minimal in ⁇ hibitory effect at concentration 0.25% and 0.5 % respectively.
- These MIC-values should be compared with the considerably higher MIC-values of 40 %, which were obtained when propylene glycol at 20 % was combined with aluminium acetotartrate (SE 8802257-9).
- MIC minimum inhibitory concentration
- the components included in the composition were weighed with decimal precision.
- a dilution series in sterile destilled water was made where the completed composition is dilution 1.
- Dilution 2 is 50 % of the composition
- dilution 3 is 25 % etc.
- To said dilutions the same amount (volume) of Oxoids Isosensitest agar was added at 62.4 g medium per litre. The Isosensitest agar is prepared and sterilized according to the maker's instructions.
- MIC-mixtures having 31.2 g Isosensitest medium per litre mixture and composi ⁇ tion concentrations of 50 %, 25 % etc. down to 0.05 %. Further ⁇ more a plate without the composition was prepared, called a blanc plate. From the different mixtures MIC-plates are moulded in sterile Petri dishes. From each agent a suspension was made corresponding to MacFarland 1. From this 0.2 ml was added to each MIC-plate and the blanc plate with a pipette. The MIC-plates were incubated in a thermostat having an optimum temperature for the agent. The MIC-value is the concentration of the composition on the MIC-plate where growth has stopped completely. Example. Agent 1 grows in 0.1 %, 0.2 %, 0.4 %, On the 0.8 %- plate the growth is weak but visible. The MIC-value for agent 1 is then 1.6 %.
- Hexylene glycol 2-methyl-2,4-pentane diol
- Butylene glycol 1,3-butane diol
- Propylene glycol 1,2-propane diol
- composition which is used according to the invention cleanses the skin due to the hygroscopic and antimicrobial properties and also because of the prominent peeling properties.
- composition according to the invention may also be used for preparing an agent having effect against such microorganisms which attack the skin and diseases caused by said microorganisms.
- the composition according to the invention is effective against Candida, Pityrosporum, Trichophyton, Microsporum, mould fungi especially Aspergillus, Staphylococcus, Pseudomonas, and viruses, especially herpes virus, hepatitis virus, wart virus and HIV-virus.
- eczema in particular seborrhoeic eczema and atopic eczema, as well as herpes and aphtha.
- Preferred cosmetic and pharmaceutical areas of use are disinfec ⁇ tion of skin, skin cleansing, sore and wound cleansing, as shampoos, soap, shower gels, softening preparations as well as peeling agents having antimicrobial effect, as skin preparations having antimicrobial effect intended to treat insect bites, as sun protection in combination with sunprotection agents or "after sun lotions".
- the composition may also be included as an additive in other cleansers and disinfecting agents to strengthen and widen the antimicrobial effects.
- a composition for cosmetic or medical use according to the invention contains preferably 0.12-40 percent in weight low molecular carboxylic acid and 0.38-91 percent by weight diol.
- additives and vehicles used in cosmetics and medicine may also be included such as, for example water, C 2 -C 8 - alcohols, polyalkylene glycols, oils with or without emulsifying agents, surfactants, antimycotics, antiviral agents, antibac- terial agents, sulphur and sulphur compounds, glucocorticoids, gels and enzymes.
- Urea may also be included in an amount of 1-20 percent by weight and thus thereby strengthen the penetration of the active substances or the effect of added enzyme.
- a product containing the above defined carboxylic acids and C 3 - C 10 -diols passes the durability (shelf life) demands which are set by the authorities concerned and thus does not need the addition of preservatives.
- Svenska Natur- skyddsfOreningen Swedish Society for the Conservation of Nature
- antimicrobial effect may be achieved with low concentrations of the diols included, which lessens the risk of side effects. This is especially favourable when the diol is used in dematological vehicles.
- a combination of carboxylic acid and a diol gives a stable, homogeneous and lasting mixture, which is almost odour-free and also may be used as an aerosol.
- the components form stable solutions with water, ethyl alcohol and polyethylene glycols. Solutions containing propylene glycol, lactic acid, polyethylene glycol, urea and glycerol have been durability tested (shelf life tested) and have shown themselves to be durable for 3 years.
- composition according to the invention may be used for treatment, cleansing and disinfecting different surfaces, mainly biological material, such as leather, skin, wood, but also plastic, metal and ceramic materials.
- Cleaning agents according to the invention differ from previously known cleaning agents and disinfecting agents containing, for example, ethyl alcohol and isopropanol, because they are both emollient and non-desiccating.
- Small skin cracks due to dryness of the skin often appear after cleansing with other disinfecting agents.
- Cleansing agents according to the invention have not caused skin cracks or drying out of the skin in the tests carried out. If the composition is used for the skin the effect works in two ways. Firstly, the infected horny layer (keratin) is removed in a mechanical way because both the components included have peeling-effects, which reduce the antigen. This reduced antigen may subsequently be killed by the antimicrobial effect of the composition.
- composition according to the invention is not volatile as ethyl alcohol it evaporates more slowly from the surface and therefor remains on and keeps its disinfecting effect for a longer time. From the fire-risk point of view the composition has also an advantage since it is comparatively less ignitible. Due to slow evaporation there are no obvious colling effects compared to ethyl alcohol. The advantages are thus many in practical use of the invention if it is used as a cleaner for table surfaces, leather surfaces and plastic coated surfaces, e.g. dentist-chairs.
- composition may form an aerosol it may easily be sprayed over large areas for quicker application. Spraying may also be used for disinfection and cleansing of wrapping material, machine components, etc. or for preventing bacteria and mould attack on certain types of foodstuffs, e.g. bread, fruit, onions, as well as flower-bulbs, tobacco and animal fodder.
- composition according to the invention is to dissolve bacteria deposits on different surfaces or in cables or pipes.
- the composition nay also be regarded as having rust dissolving effect in the light of what is previously known.
- the composition is suitable suitable as an antimicrobial effective additive in anticorrosion agents.
- the antimicrobial effect of the composition may be advantageously used so that agents need not be added.
- a buffer By adding a buffer a suitable pH may be obtained as required.
- the spraying of wood directly after sawing to inhibit the growth of surface-mould and to prevent inhalation fever in saw mill workers, is another area of use for the product according to the invention.
- the composition according to the invention has shown itself to penetrate and be absorbed well into various materials. Treatment for preventing growth of microorganisms in deeper lying struc ⁇ tures may be carried out by impregnating.
- Different materials suited for impregnating with the composition are leather; textiles, e.g. nappies, occlusive bandages, incontinence aids, tampongs, sanitary towels, dressings, plasters; clothes, innersoles for shoes; wood and paper products, e.g. refresher napkins, disposable towels, waste paper, etc.
- the invention includes also the possibility of chemically bonding the impregnating agent according to the invention to, for example, free carboxylic acid groups in different material or to polymers absorbed or adsorbed to such material, for example, textiles, wood or paper material.
- absorbed or adsorbed polymer are alginic acid or an alginate.
- Treatment according to this method then gives an antimicrobial impregnation which bonds more quickly through alginic acid to textiles and wood fibers.
- Examples of the area of use for this antimicrobial impregnation are tampongs, dressings for wounds and sores, nappies, incontinence aids and innersoles.
- composition may also be mixed with paints where oil is included or mixed in water-based acrylic paints to prevent mould and bacterial growth, instead of toxic anti-mould agents.
- the hygroscopic effects may also be an advantage since they can prevent crack-formation in wood.
- the impregnation with polyethylene glycols is an established method to obtain swelling of woodfibers and counter-act drying out and crack formation in the wood.
- Polyethylene glycols have, i.a. been used to preserve the Royal Ship Wasa.
- One problem which may arise with long-term treatment with polyethylene glycols is mould-formation, since polyethylene glycols do not have sufficient antimicrobial effect. Since the composition according to the invention is mixable with polyethy ⁇ lene glycols this new combination can prevent growth of microor ⁇ ganisms.
- a further possibility of making use of the invention is, for example, to add the composi ⁇ tion to the process water, or feed it in spray form to prevent mould-formation. Since the composition is water soluble it is easily added even to warm or cool water-systems, etc.
- the ingredients included were mixed according to generally accepted methods.
- Aqua pura may in examples 4a), 4b) and 4c) be replaced by diluted spirits or physiological saline. Gels, urea and enzymes may also be include .
- Skin preparation having antimicrobial effect a) Lactic acid 6 - 18 g Propylene glycol 10 - 30 g Hexylene glycol 10 - 30 g Oil/water-emulsion to 100 g (or aqua pura)
- Colouring agent having microbial effe ⁇ t a) Acetic acid 3 - 5 g
- Disinfecting agent for surfaces (ex. wood, plastic, leather. skin) a) Acetic acid 15 g Hexylene glycol 70 g Aqua pura to 100 g
- ethyl alcohol or isopropanol may be used. Only c) may be used as a skin disinfecting agent.
- Impregnation agent for textiles or refreshing napkins a) Lactic acid 3 - 5 g
- the hexylene glycol in example 11 may be replaced by the same amount of propylene glycol and Aqua pura may be exchanged for physiological saline.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Environmental Sciences (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9403541A SE9403541L (en) | 1994-10-14 | 1994-10-14 | Antimicrobial composition |
SE9403541 | 1994-10-14 | ||
PCT/SE1995/001191 WO1996011572A1 (en) | 1994-10-14 | 1995-10-13 | Antimicrobial composition |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0785714A1 true EP0785714A1 (en) | 1997-07-30 |
EP0785714B1 EP0785714B1 (en) | 2000-08-30 |
EP0785714B2 EP0785714B2 (en) | 2003-05-21 |
Family
ID=20395642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95934953A Expired - Lifetime EP0785714B2 (en) | 1994-10-14 | 1995-10-13 | Antimicrobial composition |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0785714B2 (en) |
KR (1) | KR970706730A (en) |
AT (1) | ATE195842T1 (en) |
AU (1) | AU3715395A (en) |
CA (1) | CA2202485C (en) |
DE (1) | DE69518656T3 (en) |
DK (1) | DK0785714T4 (en) |
ES (1) | ES2151967T5 (en) |
FI (1) | FI971516A0 (en) |
HU (1) | HUT77793A (en) |
NO (1) | NO321547B1 (en) |
SE (1) | SE9403541L (en) |
WO (1) | WO1996011572A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2334274B1 (en) * | 2008-09-18 | 2019-07-17 | Medline Industries, Inc., | Absorbent articles having antimicrobial properties and methods of manufacturing the same |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5894042A (en) * | 1996-02-26 | 1999-04-13 | Technology Licensing Company | Bacteriostatic coating of polymeric conduit |
KR20010013377A (en) | 1997-06-04 | 2001-02-26 | 데이비드 엠 모이어 | Mild, leave-on antimicrobial compositions |
AU7928698A (en) * | 1997-06-20 | 1999-01-04 | James Clair | A skin-protective composition |
BE1011314A3 (en) * | 1997-08-05 | 1999-07-06 | Sopura Sa | DISINFECTANT COMPOSITION. |
ATE201585T1 (en) | 1998-02-12 | 2001-06-15 | Oreal | USE OF 1,2-PENTANEDIOL IN A COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING FILM-FORMING POLYMER PARTICLES IN AQUEOUS DISPERSION AND COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING THE ABOVE INGREDIENTS |
ES2272051T3 (en) * | 1998-02-13 | 2007-04-16 | Carol J. Buck | USE OF COMPOSITIONS CONTAINING ALCANOIC ACID FOR THE TREATMENT OF FUNGICAL DISEASES OF THE NAILS. |
SE9801647D0 (en) | 1998-05-12 | 1998-05-12 | Interhealth Ab | Therapeutic composition |
US6527979B2 (en) | 1999-08-27 | 2003-03-04 | Corazon Technologies, Inc. | Catheter systems and methods for their use in the treatment of calcified vascular occlusions |
DE19850994A1 (en) | 1998-11-05 | 2000-05-11 | Menno Chemie Vertriebsges M B | Agent for the defense and inactivation of pathogens of plant roots, stalks, flowers, leaves and seeds |
US6294182B1 (en) | 1999-03-18 | 2001-09-25 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Towelette product for minimizing facial fine lines and wrinkles |
US6548074B1 (en) | 1999-07-22 | 2003-04-15 | Elizabeth Arden Co., Division Of Conopco, Inc. | Silicone elastomer emulsions stabilized with pentylene glycol |
US6949496B1 (en) * | 1999-08-10 | 2005-09-27 | The Procter & Gamble Company | Detergent compositions comprising hydrotropes |
US6287582B1 (en) | 1999-08-24 | 2001-09-11 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Towelette product |
ATE327779T1 (en) | 1999-12-30 | 2006-06-15 | Acrymed | METHOD AND COMPOSITIONS FOR IMPROVED DELIVERY DEVICES |
US20020172656A1 (en) | 2000-01-20 | 2002-11-21 | Biedermann Kimberly Ann | Cleansing compositions |
DE20023026U1 (en) * | 2000-01-25 | 2002-09-12 | Nutrinova Nutrition Specialties & Food Ingredients GmbH, 65929 Frankfurt | Impregnated wood and wooden objects |
AU2001245468A1 (en) * | 2000-03-20 | 2001-10-03 | Corazon Technologies, Inc. | Methods and systems for enhancing fluid flow through an obstructed vascular site |
US6372791B1 (en) | 2000-06-29 | 2002-04-16 | Johnson & Johnson Consumer Companies, Inc. | Method of promoting skin cell metabolism |
US6630175B1 (en) | 2000-06-29 | 2003-10-07 | Johnson & Johnson Consumer Companies, Inc. | Method of reducing eye irritation |
US6649176B1 (en) | 2000-06-29 | 2003-11-18 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing mineral water |
US6432424B1 (en) | 2000-06-29 | 2002-08-13 | Johnson & Johnson Consumer Companies, Inc. | Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid |
DE10105345A1 (en) * | 2000-07-14 | 2002-01-24 | Arconia Gmbh Chur | Composition for cleaning and disinfecting animal hair products, e.g. wool, pelts and furs, comprises a food preservative and a nontoxic acid |
DE10062984A1 (en) | 2000-12-16 | 2002-06-20 | Nutrinova Gmbh | Wood with fixed sorbic acid or sorbic acid salts |
US7399790B2 (en) | 2001-02-28 | 2008-07-15 | Konowalchuk Thomas W | Virucidal compositions |
DE10202167B4 (en) * | 2002-01-22 | 2004-02-26 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Use of an agent to remove and prevent deposits on mineral surfaces |
DE10205190B4 (en) * | 2002-02-08 | 2017-06-08 | Beiersdorf Ag | 2-methyl-1,3-propanediol-containing preparations |
DE10205193A1 (en) * | 2002-02-08 | 2003-08-21 | Beiersdorf Ag | Cleaning preparations containing diol |
US6858215B2 (en) | 2002-06-14 | 2005-02-22 | Carol J. Buck | Compositions and methods for softening, thinning and removing hyperkeratotic tissue |
US6835385B2 (en) | 2002-06-14 | 2004-12-28 | Carol J. Buck | Compositions and methods for softening, thinning and removing hyperkeratotic tissue |
DE20209157U1 (en) | 2002-06-13 | 2002-10-31 | Nutrinova Nutrition Specialties & Food Ingredients GmbH, 65929 Frankfurt | Detectable agent for wood treatment |
US6921529B2 (en) * | 2002-07-29 | 2005-07-26 | Joseph C. Maley | Treatment modality and method for fungal nail infection |
DE10341179A1 (en) * | 2003-09-06 | 2005-03-31 | Beiersdorf Ag | Cosmetic or dermatological preparations containing synergistic combination of alpha- or beta-hydroxyacid and alkanediol, useful for combating acne and/or Propionibacterium acnes infection |
FR2863168A1 (en) * | 2003-12-04 | 2005-06-10 | Centre Nat Rech Scient | Antibacterial agents comprising gamma--butyrolactone degradation pathway inducers, e.g. succinate semialdehyde, useful in human or veterinary medicine, plant or foodstuff protection or disinfection |
ATE521329T1 (en) | 2004-05-05 | 2011-09-15 | Unilever Nv | ACID-BUFFERED PERSONAL CARE COMPOSITIONS |
FR2869797B1 (en) * | 2004-05-10 | 2007-10-19 | Oreal | COSMETIC OR DERMATOLOGICAL COMPOSITION BASED ON A SURFACTANT, A MONOCARBOXYLIC ACID AND A POLYOL |
NZ592438A (en) | 2004-07-30 | 2012-11-30 | Kimberly Clark Co | Antimicrobial compositions of silver nanoparticles |
EP1781098B1 (en) | 2004-07-30 | 2015-10-07 | Avent, Inc. | Antimicrobial devices and compositions |
EP1809264B1 (en) | 2004-09-20 | 2016-04-13 | Avent, Inc. | Antimicrobial amorphous compositions |
BRPI0518676A2 (en) * | 2004-11-29 | 2008-12-02 | Ambria Dermatology Ab | composition, use thereof, and methods of making a composition and treating a microbial infection |
US20090306023A1 (en) * | 2005-06-29 | 2009-12-10 | Ramirez Jose E | Stable organic peroxide compositions |
US20070027119A1 (en) * | 2005-07-29 | 2007-02-01 | Ahmed Fahim U | Antibacterial composition and method of use |
US8778369B2 (en) | 2005-07-29 | 2014-07-15 | Delaval Holding Ab | Barrier film-forming compositions and methods of use |
RU2008152402A (en) | 2006-05-30 | 2010-07-10 | Дзе Дайл Корпорейшн (Us) | STRONG ANTI-VIRUS COMPOSITIONS |
CA2654079A1 (en) | 2006-06-02 | 2008-03-27 | The Dial Corporation | Method of inhibiting the transmission of influenza virus |
CA2653383A1 (en) * | 2006-06-05 | 2007-12-21 | The Dial Corporation | Methods and articles having a high antiviral and antibacterial efficacy |
WO2008009651A1 (en) * | 2006-07-18 | 2008-01-24 | Glaxo Group Limited | Anti-viral face mask and filter material |
WO2008046796A2 (en) * | 2006-10-20 | 2008-04-24 | Symrise Gmbh & Co. Kg | Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections |
HUE027381T2 (en) | 2007-04-20 | 2016-10-28 | Bioequal Ag | Topically applicable fungicide agents for treating nails |
EP2191827B1 (en) * | 2007-09-05 | 2013-10-30 | Pola Pharma Inc. | Antifungal composition |
MX2011012143A (en) * | 2009-05-15 | 2011-12-08 | Biocepta Corp | Compositions suitable for the topical treatment of fungal infections of the skin and nails. |
EP2301368A1 (en) | 2009-09-08 | 2011-03-30 | Mars, Incorporated | Composition for prevention against spoilage by microorganisms and uses and products related thereto |
HUE027470T2 (en) * | 2010-09-17 | 2016-09-28 | Abbell Ab | Treatment of fungal infections |
EP2462991A1 (en) | 2010-12-13 | 2012-06-13 | PQS Group B.V. | Composition and use of a fermented olive leaf product for the treatment of nail infections |
FR2973271B1 (en) * | 2011-03-28 | 2013-03-29 | A R C Nucleart | METHOD FOR THE DIMENSIONAL STABILIZATION OF WOOD BY IN-SITU CHEMICAL REACTION IN THE CELLULAR WALL |
WO2014169003A2 (en) * | 2013-04-09 | 2014-10-16 | Arch Chemicals, Inc. | Multi-functional composition for cosmetic formulations |
DE102015105386A1 (en) * | 2015-04-09 | 2016-10-13 | Minasolve Germany Gmbh | Stable solutions of carboxylic acids and carboxylic acid salts in aqueous alkanediols and their use |
EP3292758A1 (en) | 2016-09-07 | 2018-03-14 | Rottapharm S.p.A. | Antimicrobial composition comprising a carboxylic acid and two diols |
BR112023023046A2 (en) * | 2021-05-07 | 2024-01-23 | Genzyme Corp | COMPOSITION AND SANITIZATION METHODS |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1388836A (en) * | 1971-06-01 | 1975-03-26 | Medisan Ab | Cosmetic compositions |
GB1555796A (en) * | 1976-10-15 | 1979-11-14 | Unilever Ltd | Composition for treating acne |
FR2469450A1 (en) * | 1979-11-12 | 1981-05-22 | Solitaire Produits Entretien F | Aq. aerosol descaling and cleaning compsn. - contg. organic acid, surfactant, gelling agent and hygroscopic agent |
DE3002789A1 (en) * | 1980-01-26 | 1981-07-30 | Henkel KGaA, 4000 Düsseldorf | LIQUID CLEANING AND CARE PRODUCT |
DK315482A (en) * | 1981-07-20 | 1983-01-21 | Kimberly Clark Co | PROCEDURE FOR PREVENTING DISTRIBUTION OF SPIRIT WIRES AND METHOD FOR USING THE PROCEDURE |
SE462139B (en) * | 1986-02-04 | 1990-05-14 | Sven Moberg | Pharmaceutical composition, containing propylene glycol and carbamide before treatment of BL.A. NAIL FUNGI AND SEBORROISIC ECSMA |
IT1204304B (en) * | 1986-04-16 | 1989-03-01 | Campi Srl | ACID COMPOSITION FOR THE EXTERNAL WASHING OF RAILWAY AND SIMILAR CARRIAGES |
DE3724691C2 (en) * | 1987-07-25 | 1999-03-18 | Konrad Minninger | Pharmaceutical agent for the local therapy of flaking skin diseases |
SE464060B (en) * | 1989-06-13 | 1991-03-04 | Gunnar Swanbeck | USE OF PENTANDIOL OR HEXANDIOL FOR THE PREPARATION OF AN AGENT FOR TREATMENT OF INFECTIONS CAUSED BY HERPESVIRUS |
DE4225795C2 (en) * | 1992-07-31 | 1994-09-01 | Schuelke & Mayr Gmbh | Disinfectant based on carboxylic acid |
GB9223034D0 (en) * | 1992-11-03 | 1992-12-16 | Surtech Int Ltd | Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis |
DE4311713C1 (en) * | 1993-04-08 | 1994-05-05 | Dorothee Roesling | Cleaning lime-scale from glass, plastics and tiled surfaces - using cleaning fluid comprising citric or tartaric acid in glycerine, ethylene glycol, propylene glycol and polyethylene:glycol] |
-
1994
- 1994-10-14 SE SE9403541A patent/SE9403541L/en not_active Application Discontinuation
-
1995
- 1995-10-13 HU HU9800751A patent/HUT77793A/en unknown
- 1995-10-13 AT AT95934953T patent/ATE195842T1/en active
- 1995-10-13 ES ES95934953T patent/ES2151967T5/en not_active Expired - Lifetime
- 1995-10-13 DE DE69518656T patent/DE69518656T3/en not_active Expired - Lifetime
- 1995-10-13 WO PCT/SE1995/001191 patent/WO1996011572A1/en not_active Application Discontinuation
- 1995-10-13 DK DK95934953T patent/DK0785714T4/en active
- 1995-10-13 CA CA002202485A patent/CA2202485C/en not_active Expired - Lifetime
- 1995-10-13 KR KR1019970702423A patent/KR970706730A/en not_active Application Discontinuation
- 1995-10-13 AU AU37153/95A patent/AU3715395A/en not_active Abandoned
- 1995-10-13 EP EP95934953A patent/EP0785714B2/en not_active Expired - Lifetime
-
1997
- 1997-04-11 FI FI971516A patent/FI971516A0/en not_active Application Discontinuation
- 1997-04-11 NO NO19971676A patent/NO321547B1/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
See references of WO9611572A1 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2334274B1 (en) * | 2008-09-18 | 2019-07-17 | Medline Industries, Inc., | Absorbent articles having antimicrobial properties and methods of manufacturing the same |
US10864123B2 (en) | 2008-09-18 | 2020-12-15 | Medline Industries, Inc. | Absorbent articles having antimicrobial properties and methods of manufacturing the same |
US12036107B2 (en) | 2008-09-18 | 2024-07-16 | Medline Industries, Lp | Absorbent articles having antimicrobial properties and methods of manufacturing the same |
Also Published As
Publication number | Publication date |
---|---|
EP0785714B1 (en) | 2000-08-30 |
NO321547B1 (en) | 2006-05-29 |
DK0785714T4 (en) | 2003-09-15 |
FI971516A (en) | 1997-04-11 |
ES2151967T3 (en) | 2001-01-16 |
SE9403541D0 (en) | 1994-10-14 |
CA2202485C (en) | 2007-04-24 |
CA2202485A1 (en) | 1996-04-25 |
AU3715395A (en) | 1996-05-06 |
ES2151967T5 (en) | 2004-03-16 |
NO971676D0 (en) | 1997-04-11 |
DK0785714T3 (en) | 2000-12-27 |
DE69518656D1 (en) | 2000-10-05 |
DE69518656T2 (en) | 2001-04-19 |
NO971676L (en) | 1997-06-11 |
HUT77793A (en) | 1998-08-28 |
ATE195842T1 (en) | 2000-09-15 |
WO1996011572A1 (en) | 1996-04-25 |
FI971516A0 (en) | 1997-04-11 |
SE9403541L (en) | 1996-04-15 |
KR970706730A (en) | 1997-12-01 |
EP0785714B2 (en) | 2003-05-21 |
DE69518656T3 (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0785714B2 (en) | Antimicrobial composition | |
US5405602A (en) | Nonaqueous cold sterilant | |
JP2005530857A (en) | Antibacterial compositions, antibacterial products, and methods of using them | |
US20210204552A1 (en) | Antimicrobial composition | |
KR102699190B1 (en) | Antibacterial and Preservative Compositions | |
JP2017513951A (en) | Improved biocide composition based on calcium fluoride and use thereof | |
KR102699189B1 (en) | Antibacterial and Preservative Compositions | |
US20050020678A1 (en) | Environmentally safe fungicides | |
DE102020204730A1 (en) | Skin disinfectants | |
JP5372311B2 (en) | Stabilizer composition based on monoalkyl glycerol ether and aromatic alcohol | |
CN113274327A (en) | Amino acid foam hand sanitizer and preparation method thereof | |
US11998517B2 (en) | Antimicrobial composition | |
DE102020204728A1 (en) | Skin disinfectants | |
JP4117051B2 (en) | Antibacterial agent for tableware and cooking utensils and antibacterial agent composition for tableware and utensils | |
KR102703061B1 (en) | Antibacterial and Preservative Compositions | |
GB2620116A (en) | Antiseptic composition | |
JP2022170269A (en) | Skin coating formulation with sterilization function | |
BG704Y1 (en) | Composition of disinfectant solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17P | Request for examination filed |
Effective date: 19970403 |
|
17Q | First examination report despatched |
Effective date: 19981127 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20000830 |
|
REF | Corresponds to: |
Ref document number: 195842 Country of ref document: AT Date of ref document: 20000915 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 69518656 Country of ref document: DE Date of ref document: 20001005 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20001013 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY Effective date: 20001031 |
|
ITF | It: translation for a ep patent filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20001130 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM & CO. PATENTANWAELTE |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2151967 Country of ref document: ES Kind code of ref document: T3 |
|
PLBQ | Unpublished change to opponent data |
Free format text: ORIGINAL CODE: EPIDOS OPPO |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PLBF | Reply of patent proprietor to notice(s) of opposition |
Free format text: ORIGINAL CODE: EPIDOS OBSO |
|
26 | Opposition filed |
Opponent name: YAMANOUCHI EUROPE B.V. Effective date: 20010530 |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: YAMANOUCHI EUROPE B.V. |
|
PLBF | Reply of patent proprietor to notice(s) of opposition |
Free format text: ORIGINAL CODE: EPIDOS OBSO |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PLAW | Interlocutory decision in opposition |
Free format text: ORIGINAL CODE: EPIDOS IDOP |
|
PLAW | Interlocutory decision in opposition |
Free format text: ORIGINAL CODE: EPIDOS IDOP |
|
PUAH | Patent maintained in amended form |
Free format text: ORIGINAL CODE: 0009272 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT MAINTAINED AS AMENDED |
|
27A | Patent maintained in amended form |
Effective date: 20030521 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: AEN Free format text: AUFRECHTERHALTUNG DES PATENTES IN GEAENDERTER FORM |
|
NLR2 | Nl: decision of opposition |
Effective date: 20030521 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: RPEO |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: MARIE BIRGITTA MOBERG Free format text: MOBERG, SVEN#BOX 2057#433 02 PARTILLE (SE) -TRANSFER TO- MARIE BIRGITTA MOBERG#SINGELGRAEND 22#178 40 EKEROE (SE) |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T4 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: DR. LUSUARDI AG |
|
NLR3 | Nl: receipt of modified translations in the netherlands language after an opposition procedure | ||
NLS | Nl: assignments of ep-patents |
Owner name: MARIE BIRGITTA MOBERG |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: DC2A Date of ref document: 20030820 Kind code of ref document: T5 |
|
ET3 | Fr: translation filed ** decision concerning opposition | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: 8570 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: MOBERG DERMA AB Free format text: MARIE BIRGITTA MOBERG#SINGELGRAEND 22#178 40 EKEROE (SE) -TRANSFER TO- MOBERG DERMA AB#FOGDEVRETEN 2A#171 77 STOCKHOLM (SE) |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
NLS | Nl: assignments of ep-patents |
Owner name: MOBERG DERMA AB Effective date: 20061219 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: MOBERG DERMA AB Free format text: MOBERG DERMA AB#FOGDEVRETEN 2A#171 77 STOCKHOLM (SE) -TRANSFER TO- MOBERG DERMA AB#FOGDEVRETEN 2A#171 77 STOCKHOLM (SE) |
|
BECA | Be: change of holder's address |
Owner name: *MOBERG DERMA A.B.FOGDEVRETEN 2A, S-171 77 STOCKHO Effective date: 20070220 Owner name: *MOBERG DERMA A.B.FOGDEVRETEN 2A, S-171 77 STOCKHO Effective date: 20061218 |
|
BECH | Be: change of holder |
Owner name: *MOBERG DERMA A.B.FOGDEVRETEN 2A, S-171 77 STOCKHO Effective date: 20070220 Owner name: *MOBERG DERMA A.B. Effective date: 20061218 |
|
PLAB | Opposition data, opponent's data or that of the opponent's representative modified |
Free format text: ORIGINAL CODE: 0009299OPPO |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20141024 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20141022 Year of fee payment: 20 Ref country code: ES Payment date: 20141028 Year of fee payment: 20 Ref country code: DE Payment date: 20141024 Year of fee payment: 20 Ref country code: SE Payment date: 20141023 Year of fee payment: 20 Ref country code: CH Payment date: 20141017 Year of fee payment: 20 Ref country code: IE Payment date: 20141015 Year of fee payment: 20 Ref country code: FR Payment date: 20141031 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20141022 Year of fee payment: 20 Ref country code: NL Payment date: 20141017 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20141024 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20141017 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69518656 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MK Effective date: 20151012 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EUP Effective date: 20151013 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20151012 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MK9A |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK07 Ref document number: 195842 Country of ref document: AT Kind code of ref document: T Effective date: 20151013 Ref country code: SE Ref legal event code: EUG |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20160126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20151012 Ref country code: IE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20151013 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20151014 |